Intravesical Chemotherapy Treatment of Superficial Bladder Cancer

Lilly

Status and phase: Completed; Phase 2

Conditions: Bladder Neoplasms

Treatments: Drug: Gemcitabine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00491114

B9E-MC-S340

8192

Details and patient eligibility

About

This is a phase II study where chemotherapy (gemcitabine) is given into the urinary bladder.

Enrollment: 8 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Superficial bladder cancer
• No prior chemotherapy

Exclusion criteria

• Grade 3 tumors
• Papillary tumors invading connective tissue
• Significant urologic disease, possible interfering with intravesical therapy

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)